Perindopril

Heart Disease

Volumn 2, Issue 6, 2000, Pages 446-455

  O'Loughlin, Daniel C ^a,b   Chu, Valery L ^a   Singh, Devada ^a  

^a LONG ISLAND UNIVERSITY   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme (ace) inhibitors; Congestive heart failure; Hypertension; Perindopril

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME INHIBITORS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE; CONGESTIVE HEART FAILURE; DRUG APPROVAL; DRUG COMBINATION; DRUG EFFECT; HUMAN; HYPERTENSION; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DIURETICS, THIAZIDE; DRUG APPROVAL; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMAN; HYPERTENSION; PERINDOPRIL;

EID: 0034331374     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aceon [package insert]. Marietta, GA; Solvay Pharmaceutical, July 1999.
2. Unger T, Ganten D, Lang RE. Effect of converting enzyme inhibitors of tissue converting enzyme and angiotensin II: therapeutic implications. Am J Cardiol 1987;59:18D-22D.
3. Chrysant SG, McDonald RH, Wright JT, et al. Perindopril as monotherapy in hypertension: a multicentcr comparison of two dosing regimens. Clin Pharmacol Ther 1993;53:479-484.
4. Stumpe KO, Overlack A. A new trial of the efficacy, tolerability, and safety or angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Am J Cardiol 1993;71:32E-37E.
5. Chrysant SG. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicentcr study. J Clin Pharmacol 1997;37: 47-52.
6. Chalmers J. Efficacy and acceptability of the fixed low-dose perindopril-indapamide combination as first-line therapy in hypertension. Eur Heart J 1999; 1(Suppl L):L20-L25.
7. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
8. Bounhoure JP, Bottineau G, Lechat P, et al. Value of perindopril in the treatment of chronic congestive heart failure. Clin Exp Theor Pract 1989;A11 (Suppl 2):575-586.
9. Desche P, Antony I, Lerebours G, et al. Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Am J Cardiol 1993;71:61E-68E.
10. Kool MJ, Lustermans FA, Breed JG, et al. The influence of perindopril and the diuretic combination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995;13: 839-848.
11. Thybo NK, Stephens N, Cooper A, et al. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25(Pt 1):474-481.
12. Speirs C, Wagniart F, Poggi L. Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients. Br J Clin Pharmacol 1998;46:63-70.
13. Vandenburg MJ, Stephens JD, Resplandy G. Digoxin pharmacokinetics and perindopril in heart failure patients. J Clin Pharmacol 1993;33:146-149.